Concurrent cardiac transthyretin and brain β amyloid accumulation among the older adults: The Hisayama study

Hideomi Hamasaki1, Masahiro Shijo1,2, Ayaka Nakamura1

  • 1Department of Neuropathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Insights

Alzheimer's disease brain pathology correlates with cardiac transthyretin amyloid (ATTR) deposition in individuals aged 90 and younger. This finding highlights a link between neurodegenerative and cardiovascular changes in older adults.

Area of Science:

  • Neuropathology
  • Cardiovascular Pathology
  • Aging Research

Background:

  • Cognitive impairment is linked to cardiovascular diseases.
  • Alzheimer's disease (AD) and cardiac transthyretin amyloid (ATTR) deposition are age-related conditions.
  • Investigating the interplay between brain and heart pathologies is crucial for understanding aging and dementia.

Purpose of the Study:

  • To examine the relationship between Alzheimer's disease pathologies in the brain and cardiac ATTR deposition.
  • To assess the correlation between cerebral amyloid angiopathy (CAA), cardiac fibrosis, and AD pathologies.
  • To determine if age influences the association between cardiac ATTR deposition and AD brain pathology.

Main Methods:

  • Analysis of 240 autopsy cases from a Japanese population-based study.
  • Immunohistochemical detection and grading of brain Aβ, tau protein, and cardiac ATTR.
  • Grading of cerebral amyloid angiopathy (CAA) and quantification of cardiac fibrosis.

Main Results:

  • Cardiac ATTR deposition increased with age, particularly after 75 years.
  • ATTR deposition was more prevalent and severe in dementia cases.
  • A significant correlation was found between cardiac ATTR deposition and AD brain pathologies (Aβ phase, CERAD score, Braak stage) in individuals aged ≤90 years.
  • No significant correlation was observed between cardiac ATTR deposition and CAA, or between cardiac fibrosis and AD pathologies.

Conclusions:

  • Alzheimer's disease brain pathology is associated with cardiac ATTR deposition in individuals aged 90 years or younger.
  • The findings suggest a potential link between specific neurodegenerative and cardiovascular changes in this age group.
  • Further research is needed to elucidate the mechanisms underlying this association and its clinical implications.